eedling with blood derived platelet concentrates to increase the thickness of gum tissue
- Conditions
- Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
- Registration Number
- CTRI/2021/06/034264
- Lead Sponsor
- o funding from any agency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1.Thin gingival phenotype –gingival thickness
<1.5 mm.
2.Subjects with good general health.
3. Periodontally healthy subjects. (According
to Consensus report of workgroup 1 of the
2017 World Workshop on the Classification Of
Periodontal And Peri-Implant Diseases And
Conditions.).
1. Any systemic diseases known to
contraindicate the procedure.
2. Subjects who is under any medication that is
known to influence the thickness of gingiva
example: anticonvulsants [phenytoin],
immunosuppressant [cyclosporine A ,
calcium channel blockers[ amlodipine ,
nifidepine, verapamil, diltiazem]
3. Smokers
4. Subjects pregnancy and lactation.
5. History of periodontal surgery in the
anterior mandible.
6. Active orthodontic treatment.
7. Crowding, and marginal tissue-recession in
the anterior mandible region.
8. Subjects with clotting disorders and
platelet dysfunction.
9. Missing, impacted tooth in the anterior
region.
10. Teeth with prosthetic crowns or
restorations in the anterior mandible
region.
11. History of trauma in the anterior region.
12. Congenital & Developmental anomalies of
Bone in anterior region.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the Gingival thickness will be measured using CBCT and transgingival probing using digital callipers in mm (precision of 0.01mm using digital calliper) measured at fixed point At baseline, one month, 3 months , 6 months.Timepoint: Changes in the Gingival thickness will be measured using CBCT and transgingival probing using digital callipers in mm (precision of 0.01mm using digital calliper) measured at fixed point At baseline, one month, 3 months , 6 months.
- Secondary Outcome Measures
Name Time Method 1) Pocket Probing depth. <br/ ><br>2) Clinical attachment <br/ ><br> level. <br/ ><br>3) Keratinized tissue width.Timepoint: At baseline and 6 months